Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.
Department of Neural and Pain Sciences, University of Maryland School of Dentistry, Baltimore, MD, USA.
Psychopharmacology (Berl). 2020 Jan;237(1):93-102. doi: 10.1007/s00213-019-05347-4. Epub 2019 Aug 17.
Placebo effects in human clinical trials for depression treatment are robust and often comparable to drug effects. Placebo effects are traditionally difficult to study in rodents due to the slow-onset action of classical antidepressant drugs. We hypothesized that the rapid antidepressant actions of ketamine would allow modeling antidepressant placebo effects in rodents.
Male and female CD-1 mice received either ketamine or saline injections with concomitant exposure to specific environmental conditioning stimuli, for a total of three drug/conditioning sessions each 2 weeks apart. Two weeks later, during an evocation phase, mice were exposed to the drug-paired conditioning stimuli or no conditioned stimuli followed by testing for motor stimulatory actions and antidepressant-like effects using the forced swim test. Negative (no ketamine administration at any time) and positive (acute ketamine administration prior to evocation testing) control groups were included as comparators.
Both male and female mice exhibited increased locomotor activity following ketamine administration during the conditioning phase, which was not observed following exposure to the conditioning stimuli. Exposure to the conditioning stimuli previously paired with ketamine, similar to an acute ketamine administration, reduced immobility time in the forced swim test both 1 and 24 h after administration in male, but not female, mice.
These results represent the first evidence of antidepressant-like placebo-conditioned effects in an animal model. The developed approach can be used as a model to explore the neurobiological mechanisms of placebo effects, their possible sexually dimorphic effects, and relevance to mechanisms underlying antidepressant action.
在抑郁症治疗的人体临床试验中,安慰剂效应是强大的,通常与药物效应相当。由于传统的抗抑郁药物起效缓慢,安慰剂效应在啮齿动物中很难研究。我们假设氯胺酮的快速抗抑郁作用将允许在啮齿动物中模拟抗抑郁安慰剂效应。
雄性和雌性 CD-1 小鼠接受氯胺酮或生理盐水注射,并同时暴露于特定的环境条件刺激下,总共进行三次为期 2 周的药物/条件刺激治疗。2 周后,在唤起阶段,小鼠暴露于药物配对的条件刺激或无条件刺激,然后使用强迫游泳试验测试运动刺激作用和抗抑郁样作用。包括阴性(任何时候都没有给予氯胺酮)和阳性(在唤起测试前给予急性氯胺酮)对照组作为比较。
雄性和雌性小鼠在条件刺激阶段给予氯胺酮后均表现出运动活性增加,而暴露于条件刺激时则没有观察到这种情况。与急性氯胺酮给药相似,暴露于先前与氯胺酮配对的条件刺激可减少雄性小鼠在强迫游泳试验中的不动时间,无论是在给药后 1 小时还是 24 小时。
这些结果代表了在动物模型中首次发现抗抑郁安慰剂条件效应的证据。所开发的方法可用于探索安慰剂效应的神经生物学机制、其可能的性别二态效应,以及与抗抑郁作用机制的相关性。